ATEC Earnings Date: Feb 23, 2027 (Estimated) — Alphatec Holdings, Inc.
NASDAQ · Healthcare · Medical Devices
Updated
When is ATEC's next earnings date?
Alphatec Holdings, Inc. (ATEC) is expected to report Q4 2026 earnings on Tuesday, February 23, 2027 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.12 on revenue of $251.4M.
How did ATEC do in its last earnings report?
In its most recent report on Oct 29, 2026 (Q3 2026), Alphatec Holdings, Inc. posted EPS of $0.09 versus the $0.10 estimate, a miss of 5.4%. Revenue was $221.2M against a $225.2M estimate.
How much does ATEC stock move after earnings?
ATEC beat EPS estimates in 5 of its last 8 reported quarters. Over the last 7 reports the stock moved an average of 18.6% (up or down) in the day after earnings.
About Alphatec Holdings, Inc.
Alphatec Holdings, Inc. is a medical technology firm dedicated to engineering and advancing solutions for the surgical management of spinal conditions. Its product array includes the Alpha InformatiX platform, notably the SafeOp Neural InformatiX System, which is engineered to reduce the likelihood of nerve injury during surgery. For access and positioning, Alphatec offers systems such as the Sigma transforaminal lumbar interbody fusion pedicle-based access system, the Sigma PTP Access and Patient Positioning System, and the Squadron lateral retractor, all designed to optimize surgical outcomes. The company's robust line of spinal fixation devices features the Invictus Spinal Fixation System, capable of addressing various thoracolumbar pathologies, alongside its minimally invasive SingleStep System and adaptable Modular Fixation Systems, which enhance screw modularity. Further fixation options include the OsseoScrew system for spinal column restoration and the comprehensive Arsenal spinal fixation platform, catering to a spectrum of degenerative to deformity procedures. Alphatec also provides anterior lumbar plating solutions like the Aspida Anterior Lumbar Plating System for interbody fusion and the AMP Anti-Migration Plate, in addition to cervical fixation options such as the OCT Spinal Fixation System, the Trestle Luxe Anterior Cervical Plate System, and the Insignia Anterior Cervical Plate System. Its portfolio extends to interbody implants, including IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Implants. A comprehensive suite of biologics is also available, featuring Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier. The company additionally offers EOS imaging products. Alphatec Holdings markets its diverse product range throughout the United States via a network of independent distributors and its own direct sales force. Established in 1990, the company's headquarters are located in Carlsbad, California.
🤖 AI Earnings Analysis
Alphatec’s spine-device growth is encouraging, with revenue rising 12% year over year to $221 million, but the quarter was mixed: sales missed estimates and operating losses reached $16 million.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-29 | Q3 2026 | 0.10 | 0.09 | -5.38% | $221.2M | ❌ Miss | — | — | — |
| 2026-08-04 | Q2 2026 | 0.07 | 0.07 | +133.33% | $213.5M | ✅ Beat | -7.54% | -9.47% | -11.21% |
| 2026-05-05 | Q1 2026 | -0.03 | 0.00 | +100.00% | $192.1M | ✅ Beat | -31.67% | -24.34% | -22.58% |
| 2026-02-24 | Q4 2025 | -0.02 | 0.06 | +400.00% | $212.9M | ✅ Beat | +0.79% | -6.53% | -17.52% |
| 2025-10-30 | Q3 2025 | -0.08 | 0.03 | +137.50% | $196.5M | ✅ Beat | +16.29% | +19.47% | +34.48% |
| 2025-07-31 | Q2 2025 | -0.11 | 0.02 | +118.18% | $186.0M | ✅ Beat | +30.15% | +40.83% | +50.28% |
| 2025-02-26 | Q4 2024 | -0.07 | -0.23 | -228.57% | $176.8M | ❌ Miss | +9.58% | +3.44% | -9.13% |
| 2024-07-31 | Q2 2024 | -0.27 | -0.29 | -7.41% | $145.6M | ❌ Miss | -34.26% | -39.60% | -32.18% |
Showing last 8 quarters.
Revenue by segment & region
By region
Q3 FY26 · $221.2M total
| Segment | Share | Revenue | YoY | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 93.3% | $206.3M | +11.9% | $159.1M | $175.0M | $184.4M | $197.6M |
| Non-US | 6.7% | $14.9M | +23.0% | $10.1M | $10.5M | $12.1M | $15.3M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.